Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-02-25 @ 7:23 PM
Study NCT ID:
NCT01751269
Status:
COMPLETED
Last Update Posted:
2013-07-24
First Post:
2012-12-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects
Sponsor:
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Rempex 402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None